HCA Healthcare (NYSE:HCA) Releases Quarterly Earnings Results, Beats Estimates By $0.57 EPS

Key Points

• HCA Healthcare beat quarterly expectations, reporting adjusted EPS of $7.22 versus the $6.65 consensus estimate and revenue of $19.85 billion compared with $19.33 billion expected.
• Shares opened at $464.45, with the stock trading between $353.99 and $556.52 over the past year; HCA has a market capitalization of approximately $100.55 billion.
• Analysts maintain a “Moderate Buy” consensus, with 16 Buy, six Hold, and one Sell rating and an average price target of $467.50, despite some firms recently lowering their targets.

HCA Healthcare (NYSE:HCA - Get Free Report) released its earnings results on Tuesday. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57, FiscalAI reports. The company had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.

HCA Healthcare Price Performance

Shares of HCA opened at $464.45 on Tuesday. HCA Healthcare has a 1 year low of $353.99 and a 1 year high of $556.52. The stock's fifty day moving average price is $431.57 and its two-hundred day moving average price is $445.15. The firm has a market cap of $100.55 billion, a PE ratio of 15.55, a PEG ratio of 1.58 and a beta of 1.10.

Analysts Set New Price Targets

HCA has been the topic of several research analyst reports. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Morgan Stanley decreased their target price on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research report on Monday, July 27th. Truist Financial cut their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Finally, Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $467.50.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.